Modulation of P-Glycoprotein (PGP) Mediated Multidrug Resistance (MDR) Using Chemosensitizers: Recent Advances in the Design of Selective MDR Modulators
Current Medicinal Chemistry-Anti-Cancer Agents · 2001
DOI: 10.2174/1568011013354705 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Medicinal Chemistry-Anti-Cancer Agents, 2001. Verfasst von R Krishna und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Advanced Therapeutics, BC Cancer Agency, 600 West 10(th) Ave., Vancouver, B.C. V5Z 4E6, Canada. rajesh.krishna@bms.com. Hauptthemen laut MEDLINE: Drug Resistance, Multiple, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 40-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Advanced Therapeutics, BC Cancer Agency, 600 West 10(th) Ave., Vancouver, B.C. V5Z 4E6, Canada. rajesh.krishna@bms.com
Zitieren
APA
Krishna, R., & Mayer, L. D. (2001). Modulation of P-Glycoprotein (PGP) Mediated Multidrug Resistance (MDR) Using Chemosensitizers: Recent Advances in the Design of Selective MDR Modulators. Current Medicinal Chemistry-Anti-Cancer Agents. https://doi.org/10.2174/1568011013354705
Vancouver
Krishna R, Mayer LD. Modulation of P-Glycoprotein (PGP) Mediated Multidrug Resistance (MDR) Using Chemosensitizers: Recent Advances in the Design of Selective MDR Modulators. Current Medicinal Chemistry-Anti-Cancer Agents. 2001. doi:10.2174/1568011013354705
BibTeX
@article{Krishna2001,
author = {Krishna, R and Mayer, L D},
title = {Modulation of P-Glycoprotein (PGP) Mediated Multidrug Resistance (MDR) Using Chemosensitizers: Recent Advances in the Design of Selective MDR Modulators},
journal = {Current Medicinal Chemistry-Anti-Cancer Agents},
year = {2001},
doi = {10.2174/1568011013354705}
}
EUVIMED